Brief: Epigenomics Q3 revenue up 83 pct at 0.9 million euros

Epigenomics AG

09/11/2016 06:00

Nov 9 (Reuters) - Epigenomics AG  ECXn.DE : 
    * Full-Year 2016 revenue guidance narrowed to 3.5 million 
euros to 5.0 million euros 
    * Revenue increased by 83 pct in Q3 2016 over same period 
prior year to 0.9 million euros (Q3 2015: 0.5 
million euros) 
    * Net loss amounted to 2.3 million euros in Q3 2016 compared 
to 2.4 million euros in Q3 2015, and 10.0 million euros for 9 
months 2016 (9 months 2015: 8.0 million euros) 
    * Lower FY expected EBITDA loss to be in range of -9.5 to 
-10.5 million euros, adjusted for expenses related to phantom 
stock programs (previously -9.5 to -11.5 million euros) 
 
Source text for Eikon:  ID:nEQ3vSpsb  
Further company coverage:  ECXn.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))